Article
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.
Journal of virology - 1 Mar 1994
Richman D D, Havlir D, Corbeil J, Looney D, Ignacio C, Spector S A, Sullivan J, Cheeseman S, Barringer K, Pauletti D
Abstract excerpt
Drug susceptibility and mutations in the reverse transcriptase (RT) gene were analyzed with 167 virus isolates from 38 patients treated with nevirapine, a potent nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) RT. Resistant isolates emerged quickly and uniformly in all patients administered nevirapine either as monotherapy or in combination with zidovudine (AZT). Resistance developed as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
